Thomas Jefferson University

Jefferson Digital Commons
College of Population Health Faculty Papers

Jefferson College of Population Health

6-1-2002

Evaluation of a comprehensive diabetes disease management
program: Progress in the struggle for sustained behavior change
Janice Clarke
Thomas Jefferson University

Albert Crawford
Thomas Jefferson University

David B. Nash
Thomas Jefferson University

Follow this and additional works at: https://jdc.jefferson.edu/healthpolicyfaculty
Part of the Health Services Research Commons

Let us know how access to this document benefits you
Recommended Citation
Clarke, Janice; Crawford, Albert; and Nash, David B., "Evaluation of a comprehensive diabetes disease
management program: Progress in the struggle for sustained behavior change" (2002). College of
Population Health Faculty Papers. Paper 6.
https://jdc.jefferson.edu/healthpolicyfaculty/6

This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in College of Population Health Faculty Papers by an authorized administrator of the
Jefferson Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

DISEASE MANAGEMENT
Volume 5, Number 2, 2002
© Mary Ann Liebert, Inc.

Evaluation of a Comprehensive Diabetes Disease
Management Program: Progress in the Struggle for
Sustained Behavior Change
JANICE CLARKE, R.N., B.B.A., ALBERT CRAWFORD, Ph.D.,
and DAVID B. NASH, M.D., M.B.A.

ABSTRACT
The successful management of diabetes with a goal of achieving near-normoglycemia requires
patients to make multiple lifestyle changes as part of an intensive, complex, and coordinated
therapeutic regimen aimed at reducing the risk of complications associated with the disease.
The difficulty in creating and sustaining these lifestyle behavior changes is a major stumbling block in achieving the desired therapeutic goal. An underlying assumption of comprehensive disease management is that regular, personal contact with nurses and ancillary health
professionals will facilitate these lifestyle behavior changes for program participants. The results of a survey of self-reported data from 750 participants in a comprehensive diabetes management program, reported on here, show strong perceptions of positive behavior change over
the broad range of medical and lifestyle treatment areas associated with effective management of diabetes. These results suggest that diabetes disease management programs are an
effective approach to helping diabetic patients accomplish the lifestyle behaviors critical to
their health.

turbingly under-diagnosed, diabetes affects
nearly 16 million U.S. individuals and contributes to almost 200,000 deaths per year.1 Total
direct and indirect costs attributed to diabetes
in the United States approach $105 billion per
year.2 As the population continues to age, so
the prevalence and the costs of diabetes are expected to rise. Recent studies project a rise of
at least 15% by the year 2010 and 60% by 2050.3
For people with diabetes, adhering to recommended treatment regimens has never been
simple; but in recent years it has become a formidable challenge. Based on compelling evidence from two landmark studies, the Diabetes
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such as diabetes, asthma,
coronary artery disease, and hypertension
have replaced acute and infectious diseases as
the major cause of death and disability in the
United States. According to statistics reported
by the Institute on Health and Aging, chronic
diseases affect over 100 million Americans and
account for 75% of national health care costs.
Among chronic diseases, diabetes may be the
“poster child,” with its broad-ranging complexity and costliness, in both human and financial terms. Increasingly common and disHRONIC DISEASES
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Control and Complications Trial (DCCT) and
the United Kingdom Prospective Diabetes
Study (UKPDS),4,5 the current treatment goal
for people with diabetes has escalated from
mere blood glucose control to near-normoglycemia. The DCCT and UKPDS studies demonstrated the importance of optimal glucose
control in reducing the risk, or delaying the
progression, of serious complications of the
disease for both type 1 (insulin dependent) and
type 2 patients. With near normoglycemia as
the new “gold standard,” the ongoing care and
treatment strategies recommended by the
American Diabetes Association (ADA) have intensified.6 More frequent monitoring and sustained adherence to medication, diet, and exercise regimens are typically required to
achieve the desired level of glycemic control. It
follows that providing optimal treatment
makes greater demands of the primary care
provider—and achieving the best outcomes
places increased burdens on the diabetic patient, physician, and health care system alike.
Diabetes is one of the most psychologically
and behaviorally demanding of the chronic
medical illnesses.7 The outcome of diabetes
treatment is highly dependent on the self-care
behavior of the patient. It is estimated that patients are expected to conduct 95% of their own
diabetes management.8 Patients with diabetes
are expected to make multiple lifestyle changes
simultaneously. The complexity involved in
achieving optimal control requires almost “fanatic-like” behavior from the patient with diabetes as he or she strives to understand the effect of exercise, medications, dietary intake,
and stress on blood glucose levels. Moreover,
the self-management process is not static—patients must learn to understand the complex
physiological changes in their bodies and to incorporate these changes into their self-management decisions.9
Failure to sustain desired behaviors is associated with a high risk of complications, but patients with diabetes often do not fully understand their illness, take their medication
correctly, or make lifestyle changes recommended by their physicians. Further, they often lack the emotional support necessary for
coping with their condition.10
Collaborative relationships between health
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care providers and their patients with diabetes
may be the most important element in improving patient adherence and outcomes. 8 However, for time-pressed primary care providers
who manage the clinical care of most of these
patients, the demands for medical care, monitoring, social and emotional support, education
and reeducation required by this complex, progressive disease are often overwhelming. Statistics reported by the U.S. Department of
Health and Human Services (DHHS) in 2000
suggest that medical care for diabetes as currently practiced in the United States neither
meets the ADA guidelines nor approaches the
levels of the treatment groups documented in
the DCCT or UKPDS.15 While a variety of reasons are generally offered for this, perhaps the
most valid explanation is the lack of an integrated, coordinated care management system
designed to support both the patient and the
physician in creating and sustaining the desired
self-management behaviors across the entire
health care delivery spectrum.
Contributions of behavioral science and
diabetes education
Nonadherence to medication regimens is a
major problem in all therapeutic areas, ranging
from 30% to 60%, with the higher rates occurring in symptom-free patients.11 As noted by
Glasgow et al. in their review of behavioral science contributions, 12 other studies have found
that, while adherence to medication regimens
is a problem, compliance is poorest in the areas involving other lifestyle modifications such
as dietary change and home glucose monitoring.
Behavioral science has developed theories
and provided frameworks for understanding
and studying nonadherence and its determinants. The Health Belief Model (HBM), for instance, recognizes and explains the relationship
between perceived health benefits and a patient’s success with self-care. The Transtheoretical Model described by Prochaska et al. defines behavior change as occurring in five
distinct stages: precontemplation, contemplation, preparation, action, and maintenance.13
While a theoretical model, it is particularly useful in diabetes education in that it recognizes
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behavior change as a continuum and identifies
success in terms of progress toward change as
well as in terms of a realized outcome of the
change.
The field of diabetes education has also produced insights into diabetes patient behavior
change and “self-efficacy.” The concept of “patient empowerment” has been applied to diabetes education to ensure that the choices made
by patients living with diabetes are informed
choices. Studies suggest that patient empowerment is an effective approach to developing educational interventions for addressing the psychosocial aspects of the disease and, by
implication, that it is conducive to improving
blood glucose control.14
The translation of these behavioral concepts
into practice requires systems and resources
designed to support both patients and physicians in actualizing the behavior changes identified as critical success factors for effective selfmanagement.
Disease management as an approach for creating
and sustaining positive behavior change
Patient success in adhering to healthcare regimens requiring changes in behavior and
lifestyle is associated with rapport with health
care professionals who play a role in engendering optimism, maintaining enthusiasm, and
facilitating and encouraging maintenance of
health behaviors.10 Traditional strategies have
focused on diabetes education classes with certified diabetes educators and nutritionists, and
diabetes education assistance in physicians’ offices, often provided as outreach by teaching
hospitals. The ADA has advocated a physiciancoordinated team approach to diabetes care
management. These teams might include
nurses, nutritionists and behavioral health professionals with expertise in diabetes care and
treatment. There is considerable evidence that
these traditional educational approaches have
positive effects on outcomes. However, these
approaches would be difficult to apply to large
numbers of patients with diabetes simultaneously. They do not offer promise as a resolution to the national delivery system problems
underlying the DHHS findings cited above.
Over the past decade, disease management
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programs have emerged as a framework for
supporting interventions to effect positive behavior changes in patients with chronic illnesses, particularly diabetes. Disease management is generally defined as “a system of
coordinated healthcare interventions and communications for populations with conditions in
which patient self-care efforts are significant”
(DMAA Definition of Disease Management).
Focusing on both clinical and non-clinical interventions, disease management programs address a disease or condition in a manner that
maximizes effectiveness and efficiency regardless of treatment settings or customary reimbursement methods. The overriding goal is to
prevent acute exacerbation of the disease and
the accompanying use of expensive resources
by emphasizing prevention, proactive care
management and effective integration and coordination of care processes across the provider
spectrum. 16 Through this approach, disease
management programs help patients and their
physicians to better adhere to the recognized
standards of care and prevent avoidable utilization of health care resources.
Proponents of disease management believe
that, when effectively designed and implemented, it offers substantial promise to improve health outcomes, thereby reducing overall costs. The disease management model shifts
the focus from “utilization management” (i.e.,
targeting the sickest and/or highest risk patients) to a population-based approach involving identification and stratification of all patients diagnosed with a particular disease. In
combination with the structures of modern
health plans, the disease management model
presents a powerful opportunity for improving
upon the traditional model for managing diabetes. Existing health plan structures incorporate the requisite range of healthcare providers
and services, provide operational and informational tools to support positive change, and
are the repository for the data necessary to
manage change.
On a national level, the Institute of Medicine
(IOM) has recognized the enormous potential
of the disease management model. In “Crossing the Quality Chasm: A New Health System
for the 21st Century,” the IOM calls for the expansion of disease management services for
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chronic illnesses as an integral part of a
smoothly functioning healthcare system.
American Healthways (AMHC): description of
the Diabetes HealthwaysSM program
American Healthways, a recognized leader
in the field of disease management and the
largest publicly traded disease management organization in the nation, has successfully partnered with health plans to enhance the care of
their members with chronic diseases. AMHC’s
disease-specific “Healthways” programs offer
a broad scope of services and components from
which a health plan may tailor a program to its
unique member population and provider network. A distinctive feature of the Diabetes
HealthwaysSM program is that once a patient
is identified and participating, the program coordinates all of the patient’s health care needs.
In providing support to patients, whether or
not their needs are related to diabetes, the program effectively treats the person rather than
the disease.
In 2000, AMHC contracted to provide a comprehensive diabetes disease management program for a health plan serving approximately
800,000 members over a statewide area in the
midwestern United States. Under the terms of
this agreement, AMHC provided its Diabetes
HealthwaysSM program to the plan’s “risk” and
“Medicare 1 Choice” members diagnosed
with diabetes who did not opt-out of participation. (Note: The “opt-out” rate for this plan
was 3%.)
AMHC’s programs are provided on an “engagement” basis to all of the health plan’s subscribers identified as having diabetes through
retrospective review of pharmaceutical and
other medical claims; that is, all identified diabetics are automatically enrolled rather than invited to enroll. Once identified and enrolled,
diabetic members are classified according to
AMHC’s proprietary, four-tiered population
stratification model to assure that members receive the appropriate frequency and intensity
of interventions. The strata range from the
healthiest group (stratum 1), currently showing no indicators for meaningful risk of health
compromise, to the highest risk group (stratum
4), with severe health and/or behavior prob-
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lems adversely affecting their health status. The
initial stratification incorporates behavioral
data provided by the member and the primary
physician in addition to health status information and utilization patterns provided by the
health plan. The stratification model is dynamic, allowing for changes based on new data
and the member’s changing health status.
The AMHC Diabetes HealthwaysSM program is based on American Diabetes Association Guidelines and features ADA Standards of
Care in its core content. The program protocol
for all participants, regardless of stratification
level, includes mailed letters of introduction
and welcome kits; scheduled outbound “Care
Calls” as well as a “hot line” for inbound member calls; and periodic “reminder card” and
newsletter mailings. The program provides
parallel communications—for example, introductory letter and welcome kit, Standard of
Care notices—with the members’ primary care
physicians. An electronic database equipped
with proprietary software enables AMHC personnel to track program participants’ medical
claims, drug prescriptions, nature and frequency of laboratory tests and, in most cases,
laboratory test results.
The core of the program is the “Care Call,”
an outbound personal communication between
a specially trained nurse and the patient. Care
Calls are regularly scheduled telephonic interactions between AMHC’s nurses and program
participants. Each call may include, but is not
limited to: diabetes education, including identification of knowledge deficits; establishment
of and progress in meeting self-care goals; review of adherence to medication regimen and
the primary physician’s treatment plan; review
of specific problems and interventions initiated
to address those issues; identification of new
problems the member is experiencing; and reminders about standards of care. Typically,
Care Calls reinforce positive behaviors such as
taking medications as prescribed, adhering to
appointment schedules, and doing or getting
appropriate medical tests. AMHC’s nurses also
discuss diabetes-specific preventive measures,
stress factors and, if relevant, smoking cessation and alcoholic beverage consumption. On
an annual basis, the nurses administer a General Health Assessment, a Depression Risk As-
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sessment Screening, and a Quality of Life
Survey for each program participant. The frequency of scheduled Care Calls ranges from
quarterly to daily according to stratification
level and individual patient needs.
For participants in all but the lowest risk stratum (asymptomatic), the program features the
formation of a documented self-care goal
agreement focused on defining a plan for positive behavior change. This is accomplished
telephonically, and is supplemented by a series
of scheduled Care Calls providing individualized education, advocacy and physician treatment plan support. On an acute basis, calls focus on problem-specific assessments and
problem-specific interventions. The intensity
and frequency of calls follows the proprietary
stratification protocol. Communication of critical information or “alert values” to physicians
is made as appropriate.
Central to the effectiveness of the Care Call
is the development and maintenance of trusting relationships between AMHC’s nurses and
the program participants. It is hypothesized
that these regularly occurring, personal contacts with the nurses (and other ancillary health
professionals who make up the patient’s
AMHC care team) help patients to manage
their diets, achieve blood glucose and cholesterol targets, and in general facilitate the behaviors necessary for reducing the incidence of,
or retarding the development of, complications.
An overriding goal of AMHC’s Diabetes
HealthwaysSM program is to reinforce the positive behaviors, attitudes, skills, and knowledge of its participants. Patient adherence to
medical treatment regimens, and the requisite
lifestyle modifications, is expected to bring
about the desired clinical outcomes, and, as a

TABLE 1.

result, the desired financial outcomes. Aggregate clinical process and cost data indicate that
the program is achieving these objectives.
MATERIALS AND METHODS
Evaluation of the overall impact of the Diabetes HealthwaysSM program typically includes clinical quality process and objective
outcome measures, member and physician satisfaction measures and financial measures. Because patient behavior change is so critical to
the success of a diabetes management program,
AMHC undertook a study to assess the presence and extent of positive behavior changes in
enrolled diabetes patients as part of its overall
process for regular and comprehensive program quality evaluations.
Study design, population, and sampling rationale
As illustrated in Table 1, a five-group, proportionally allocated, random sampling design
was employed to quantify the extent to which
program participants perceived that their behaviors changed since enrolling in the program.
The sample was drawn from the entire eligible population in order to obtain a statistically valid set of responses representative of
that population. To be included in the study,
diabetes members (i.e., members with diabetes as their primary medical condition,
without any evidence of congestive heart failure) must have been documented as continuously enrolled between the initial date of
member eligibility and the study population
creation date (10/31/2001), and must have received a minimum of one Care Call. To ensure appropriate representation of all inter-

PROPORTIONAL ALLOCATION

OF

STUDY POPULATION

Group

No. of care calls

Population

No. of completed surveys

1
2
3
4
5
Total

1–2 Care Calls
2–3 Care Calls
3–6 Care Calls
6–8 Care Calls
Over 8 Care Calls

431
430
430
430
430
2,151

149
150
149
149
151
748
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vention levels in the study, members meeting
study inclusion criteria were arrayed from
least to most Care Calls, providing the basis
for the five groupings. From this ordering,
members were divided into five proportionally allocated groups. Further, members
within each group were randomized to ensure that the final sample would accurately
represent the population from which it was
drawn.
Survey instrument and method of administration
The survey instrument, a 10-item questionnaire with a four-point rating scale (plus a “not
applicable/don’t know” rating), was developed by AMHC’s Informatics Department. The
questions were designed to elicit participant
perceptions regarding changes in their behavior in the key areas addressed, that is, eating
habits, taking medications and recommended
tests, attending to test results, stopping/reducing smoking and drinking, increasing physical
activity, increasing use of preventive health
services, and reducing stress. The survey was
administered telephonically by an unaffiliated,
independent market research organization that
provided training on appropriate interview
techniques to its staff. Survey calls were monitored and completed surveys were reviewed
at random by supervisory staff. In order to assure equal representation across the five
groups, approximately 150 surveys were completed per group (Table 1).
Survey inclusion criteria
To be eligible for inclusion in the study,
members were required to meet the following
minimum qualifications: documented as being
continuously enrolled in the disease management program from the program’s inception
date or from the date of eligibility; 18 years of
age or older as of 10/31/2001; having a valid
telephone number; and having a minimum of
one successfully completed Care Call.

RESULTS
A total of 1,720 telephone calls were attempted in order to complete a total of 748 surveys (a 43% success rate). There were no sig-

nificant age or gender effects—the average age
of respondents was 59 years and 386 (51%) respondents were female. Forty-one percent (305)
of respondents received a “high number” (six
or more) of Care Calls, and 59% (447) received
a “low number” of Care Calls (less than six).
The average number of Care Calls received per
respondent was 5.18. When viewed by risk
stratification level, the respondent group
closely reflected the distribution of the total
program population: 24 (3%) in stratum 1; 299
(40%) in stratum 2; 354 (47%) in stratum 3; and
75 (10%) in stratum 4. Likewise, the age distribution for survey respondents was similar to
that of the population: 87 (11%) at 18–44 years
of age; 396 (54%) at 45–64 years of age; and, 262
(35%) greater than 64 years of age.
Table 2 contains the frequency distribution
of responses by question. As illustrated, the total perceived behavior change (i.e., all responses of “somewhat,” “moderately,” and “a
lot”) ranged from a low of 65.2% on question
5 (“stopped or reduced smoking”) to a high of
93.9% on question 7 (“improved on taking recommended medical tests”). Total responses to
question 5 (“stopped or reduced smoking”)
and question 6 (“stopped or reduced drinking”) suggest that relatively few of these program participants were preintervention smokers and/or drinkers. “Not applicable” was the
answer given by 62% (544) of the respondents
for question 5 and by 74% (594) of the respondents for question 6. Disregarding questions 5
and 6, over 87% of the total responses for the
other eight questions support the assertion that
participation in the AMHC Diabetes HealthwaysSM program effects favorable behavioral
change.
A general linear model (GLM) was developed to examine the effects of risk stratification levels and Care Calls on perceived behavior change indicators. Table 3 shows mean
scores for each survey question (excluding
question 5 and question 6) by Care Call frequency group, including statistical controls
for the effects of Risk Stratification Level. For
example, respondents receiving one to five
Care Calls had a mean perceived improvement in eating habits of 3.26 (where the number “3” represents the response “moderately”
and the number “4” represents the response
“a lot”), while those respondents receiving six

83

COMPREHENSIVE DIABETES DISEASE MANAGEMENT PROGRAM
TABLE 2.
Indicator/
survey
question
1. Improved eating
habits
2. Improved taking
medications
3. Increased physical
activity
4. Increased discussion
about medical
condition
5. Stopped or reduced
smoking
6. Stopped or reduced
drinking
7. Improved on taking
recommended medical
tests
8. Paid closer attention
to medical results
9. Increased use of
preventive health
services
10. Spent less time
worrying about
condition
a Total

FREQUENCY DISTRIBUTIONS : BEHAVIOR CHANGE INDICATORS

Not at all

Somewhat

Moderately

A lot

Total
behavior
changea

95
13.63%
105
14.8%
111
15.42%
86
11.65%

352
50.50%
256
36.16%
324
45.00%
271
36.72%

160
22.96%
175
24.72%
196
27.22%
237
32.11%

90
12.91%
172
24.29%
89
12.36%
144
19.51%

602
86.37%
603
85.17%
609
84.58%
652
88.34%

72
34.78%
40
25.64%
45
6.14%

58
28.02%
56
35.90%
250
34.11%

47
22.71%
39
25.00%
279
38.06%

30
14.49%
21
13.46%
159
21.69%

135
65.22%
116
74.36%
688
93.86%

46
6.22%
80
10.85%

220
29.73%
260
35.28%

232
31.35%
242
32.84%

242
32.70%
155
21.03%

694
93.78%
657
89.15%

131
18.40%

273
38.34%

197
27.67%

111
15.59%

581
81.60%

behavior change is the sum of the values of "somewhat," "moderately," and "a lot."

or more Care Calls had a mean perceived improvement of 3.47.
Where significant, the effects of Care Calls
on behavior change indicators when control-

ling for risk stratum are shown. Both the risk
stratum and the number of Care Calls appear
to have an effect on perceived behavior
change.

TABLE 3. GENERAL LINEAR MODELa RESULTS: PERCEIVED BEHAVIOR CHANGE MEAN SCORE
NUMBER OF CARE CALLS , CONTROLLING FOR AGE GROUP, GENDER , AND RISK STRATUM

BY

BCI: 1–5
care calls

BCI: 61
care calls

1. Improved eating habits

3.26

3.47

2. Improved taking medications
3. Increased physical activity
4. Increased discussion about medical
condition
7. Improved on taking recommended
medical tests
8. Paid closer attention to medical results

3.58
3.36
3.50

3.59
3.37
3.73

3.68

3.86

3.81

4.04

3.60

3.70

F
p
p
p
F
p
F
p
F
p
p

3.35

4.49

p 5 n.s.

Indicator/survey questionb

9. Increased use of preventive health
services
10. Spent less time worrying about
condition
a SAS

PROC GLM for unbalanced analysis of variance (ANOVA) designs.
5 and 6 (reducing smoking and drinking) were excluded from these analyses.

bQuestions

F, p
5
,
5
5
5
,
5
,
5
,
5

5.85
0.05
n.s.
n.s.
8.11
0.01
5.58
0.05
8.93
0.01
n.s.
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The survey findings are even more persuasive when viewed in combination with clinical
process outcomes for the program. More than
93% of survey respondents reported improvement in taking recommended medical tests. As
shown in Table 4, there were dramatic, program-wide increases in testing for HbA1c, LDL
cholesterol, diabetic retinopathy and microalbuminuria for the enrolled diabetic population
during the first year of the Diabetes HealthwaysSM program.
Of further interest are the results of a cost
analysis for the program. In the relatively
short-term (the first year of the program), costs
for program participants (i.e., total population
of members with diabetes, with or without
CHF) decreased from an adjusted baseline of
$559.44 PM/PM (1999) to $503.07 PM/PM for
the study period, a 10.1% reduction. For the
same period, costs for the nondiabetes members in this health plan increased by 21.2%.

DISCUSSION
The Care Call component of the Diabetes
HealthwaysSM program focuses on improving
participants’ understanding of their disease
and the crucial importance of adhering to the
recognized standards of care while providing
support in helping them to change their behaviors and lifestyles to accommodate the intensive treatment regimens. The findings of
this survey of perceived behavior change in
program participants are uniformly positive,
strongly so in a majority of the areas emphasized by the Diabetes HealthwaysSM program.

TABLE 4.

CHANGES
ENROLLED

IN
IN

It is recognized that self-reported measures
must be viewed with some caution. For example, a recent study examining the relationship
between actual Hb A1c test rates and various
self-reported measures of health status found
substantial differences between the patients’
perceptions of health status and satisfaction
with care and the actual medical care they received.17 Nevertheless, the findings of this survey show a strong correlation between perceived behavior change and actual outcomes,
suggesting a high probability of causality.
It is impossible to establish absolute causality when dealing with a complex, multifaceted
program for a disease such as diabetes. In addition to internal programmatic factors, external factors ranging from the increase in public
awareness of diabetes to the involvement of the
National Committee on Quality Assurance
(NCQA) in monitoring diabetes treatment
(HEDIS standards reporting requirements) introduce variables of indeterminate impact on
the behavior of participants in disease management programs.
An obvious weakness in the study is the lack
of a clinical outcomes measure, i.e. a change in
the HbA1c test results for the study population.
However, behavioral scientists such as
Sanazaro and Williamson make a strong case
that, while not a direct measure of improvement or deterioration in health status, compliance may be influenced by and/or result from
a health care intervention, leading to improved
outcomes. 18 They make a convincing case for
“compliance” as a valuable process outcome.
Some have defined compliance as an “intermediate outcome” which is useful in evaluat-

CLINICAL QUALITY PROCESS MEASURES FOR MEMBERS
DIABETES DISEASE MANAGEME NT PROGRAM

Baseline (1999), n 5 2,982

First year (6/00–5/01), n 5 3,144

Process measure

Number (%)

Number (%)

At least 1 HbA1c
At least 2 HbA1c
LDL
DRE
Microalb.

1,581
755
1,056
523
399

2,441
1,547
1,980
735
993

a Critical

value of p 5 0.001: 10.827.

(53.0)
(25.3)
(35.4)
(17.5)
(23.4)

(77.6)
(49.2)
(63.0)
(23.4)
(31.6)

Chi-square value
2,175 (p
1,065 (p
1,600 (p
201 (p
570 (p

,
,
,
,
,

0.001)a
0.001)a
0.001)a
0.001)a
0.001)a

COMPREHENSIVE DIABETES DISEASE MANAGEMENT PROGRAM

ing the means by which a disease management
program can improve outcomes. Self-reported
or objective measures of adherence/compliance are included in this definition.
Specific characteristics of a population dramatically affect behaviors, perceptions and outcomes. The subjects in this study were members of a commercial health plan in the
southwestern United States. A multicultural,
northeastern, urban population may have very
different motivators and responses than the
population represented in the study. Given
previous geographically dispersed outcomes
reported for other health plans using AMHC’s
Diabetes HealthwaysSM programs, we suspect
that the results found in the population studied are likely to be similar in other populations.

CONCLUSION
Comprehensive patient-centered diabetes
management programs, focused on providing
proactive, personal support for patients with
diabetes, hold promise for ending the struggle
to create and sustain patient behavior change.
Results of a survey of 750 participants in a Diabetes HealthwaysSM diabetes disease management program show strong evidence of perceived positive behavior change in ten critical
treatment areas. When viewed in combination
with positive clinical process outcomes and reduced PMPM costs for the entire program,
these findings are even more compelling. While
the survey does not prove any causal linkages
as a result of the Diabetes HealthwaysSM program, it does demonstrate that the perceived
changes were not the result of random chance.
Absent any other significant factors, it is reasonable to conclude that the program was a primary contributor to both the perceived and reported results.
Increasingly, behavioral scientists are recognizing diabetes treatment as predominantly behavioral, that is, promoting self-management. 12
There is ample evidence in the health behavior
literature of a growing acceptance of behavior
change as an outcome—or “intermediate outcome”—on its own merits. In evaluating the
performance of a multifaceted disease management program such as Diabetes Health-
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waysSM , a measure of behavior change is valuable, particularly when viewed in combination
with improvement in patients’ health status
and satisfaction as well as in terms of cost savings.
In “Crossing the Quality Chasm,” the Institute of Medicine (IOM) recognized the pivotal
role of ongoing management of chronic illness
in a smoothly functioning healthcare system
and called for expansion of disease management services.19 The IOM has also called for additional research into appropriate outcome
measures for gauging the success of disease
management programs. Progress is being made
in developing universally accepted definitions
of the attributes of disease management programs such as optimal program delivery (e.g.,
means of identification, engagement versus enrollment, telephone versus on-line), components, and outcomes reporting. The Disease
Management Association of America (DMAA)
has published an industry standard definition
and is embarking on an effort to develop an industry standard outcomes reporting methodology. Other organizations such as the National
Committee on Quality Assurance (NCQA) and
the Disease Management Advisory Council
(DMAC) are making headway on accreditation
and evaluation programs for disease management.
Validated and peer-reviewed large-scale outcomes studies from comprehensive diabetes
disease management programs are beginning
to appear regularly in the literature. The sum
impact of these studies is strongly positive in
demonstrating the effectiveness of these programs in helping participants to make and sustain the behavior changes necessary for improving their health status while reducing
costs.
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